NCT03705312 - MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

February 22, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions

Mitral RegurgitationHeart FailureMitral Valve Regurgitation Due to Cardiomyopathy (Disorder)

Interventions

DEVICE

Transcatheter mitral valve repair

Transcatheter mitral valve repair performed using the MitraClip device

OTHER

Guideline-directed medical therapy

Standard medical therapy for heart failure as recommended by HF guidelines

Trial Locations (1)

RECRUITING

Montreal Heart Institute, Montreal